Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (113) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter CMDh final position (3) Apply CMDh final position filter Under evaluation (1) Apply Under evaluation filter

Referral safety status

Yes (5) Apply Yes filter

Referral type

Article 30 referrals Remove Article 30 referrals filter Article 29 paediatrics Remove Article 29 paediatrics filter Article 13 referrals Remove Article 13 referrals filter Article 107i procedures Remove Article 107i procedures filter Article 29(4) referrals (116) Apply Article 29(4) referrals filter Article 31 referrals (99) Apply Article 31 referrals filter Article 33 (43) Apply Article 33 filter Article 35 (42) Apply Article 35 filter Article 20 procedures (22) Apply Article 20 procedures filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 34 (18) Apply Article 34 filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 13 (6) Apply Article 13 filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 78 (5) Apply Article 78 filter Articles 39 and 40 (4) Apply Articles 39 and 40 filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CMDh (5) Apply PRAC-CMDh filter

Referral authorisation model

Nationally authorised product(s) (7) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (4) Apply Risk minimisation measures filter Suspension (1) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Related medicine

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

113 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral type Article 30 referrals Remove Article 30 referrals filter Article 107i procedures Remove Article 107i procedures filter Article 13 referrals Remove Article 13 referrals filter Article 29 paediatrics Remove Article 29 paediatrics filter

Referral status European Commission final decision Remove European Commission final decision filter

Sort by

List item

Referral: Cozaar

irbesartan, associated names: Loortan, Loortan Cardio Start, Cozaar Startpakkle, Cardopal Start, Lorzaar, Lorzaar start, Lorzaar Protect, Pinzaar, Lorzaar Varipharmstart, Lortaan, Neo-Lotan, Losaprex, Cozaar IC, Lortaar IC, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 23/10/2008, EC decision date: 22/01/2009, Last updated: 13/01/2012
List item

Referral: Vascace Plus

cilazapril/hydrochlorothiazide, associated names: Co-Inhibace, Dynorm Plus, Inhibace Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/01/2011, Last updated: 09/11/2011
List item

Referral: Atacand Plus

candesartan / hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011
List item

Referral: Losec

omeprazole, associated names: Antra, Logastric, Losec Forte, Mopral, Omeprazen, Omeprazole, AstraZeneca, Zoltum, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/01/2010, EC decision date: 10/06/2010, Last updated: 19/09/2011
List item

Referral: Lescol

fluvastatin, associated names: Canef, Cardiol, Cardiol XL, Cranoc, Digardil, Digaril Prolib, Fluvastatin Novartis, Fluvastatina, Fractal, Leposit Prolib, Lescol Depot, Lescol Exel, Lescol LP, Lescol MR, Lescol Prolib, Lescol XL, Lipaxan, Lipaxin, Liposit, Locol, Lymetel, Primesin, Vaditon, Vaditon Prolib, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/11/2009, EC decision date: 15/03/2010, Last updated: 13/09/2011
List item

Referral: Kytril

granisetron, associated names: Kevatril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/05/2011, EC decision date: 20/07/2011, Last updated: 12/09/2011
List item

Referral: Famvir

famciclovir, associated names: Famciclovir-Sandoz, Famciclovir-SB, Famciclovir-SB Zoster, Famvir Zoster and Oravir, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 09/09/2011
List item

Referral: Arimidex

anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011
List item

Referral: Sortis

atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 27/04/2011
List item

Referral: Sortis

atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 27/04/2011
List item

Referral: Sortis

atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 27/04/2011
List item

Referral: Daivobet

calcipotriol and betamethasone, associated names: Dovobet, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 30/09/2010, Last updated: 26/04/2011
List item

Referral: Atacand

candesartan, associated names: Amias, Blopress, Kenzen, Racanda, Ratacand, Parapres, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 13/07/2010, Last updated: 16/03/2011
List item

Referral: Xalatan

latanoprost, associated names: Latanoprost Pharmacia & Upjohn, Xalatan 50 mikrogramov/ml kaplijice za oko, raztopina, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 15/10/2010, Last updated: 08/12/2010
List item

Referral: Fortum

ceftazidime, associated names: Cefortam, Glazidim, Panzim, Solvetan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 13/01/2011, Last updated: 22/10/2010
List item

Referral: Vascace

cilaprazil, associated names: Dynorm, Inhibace, Inibace, Justor, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 07/07/2010, Last updated: 19/10/2010
List item

Referral: Diovan

valsartan, associated names: Angiosan, Diovane, Tareg, Cordinate, Provas, Dalzad, Rixil, Kalpress Cardio, Diovan Cardio, Miten Cardio, Valsartan Novartis, Kalpress, Miten, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 15/12/2009, EC decision date: 19/04/2010, Last updated: 31/05/2010
List item

Referral: Diovan

valsartan, associated names: Angiosan, Diovane, Tareg, Cordinate, Provas, Dalzad, Rixil, Kalpress Cardio, Diovan Cardio, Miten Cardio, Valsartan Novartis, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 15/12/2009, EC decision date: 19/04/2010, Last updated: 31/05/2010
List item

Referral: Arimidex

anastrozole, Article 29 paediatrics
Status: European Commission final decision, EC decision date: 06/11/2009, Last updated: 28/05/2010
List item

Referral: Topamax

topiramate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 01/10/2009, Last updated: 15/12/2009
List item

Referral: Meronem

meropenem, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/07/2009, EC decision date: 15/10/2009, Last updated: 12/12/2009
List item

Referral: Diovan Comp

valsartan and hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 26/05/2009, Last updated: 11/06/2009
List item

Referral: Zoloft

sertraline, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 27/03/2009, Last updated: 07/05/2009
List item

Referral: Tritace

ramipril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 06/03/2009, Last updated: 24/04/2009
List item

Referral: Tritazide

ramipril and hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 06/03/2009, Last updated: 14/04/2009

Load more

113 results

Referral: Cozaar

Referral: Vascace Plus

Referral: Atacand Plus

Referral: Losec

Referral: Lescol

Referral: Kytril

Referral: Famvir

Referral: Arimidex

Referral: Sortis

Referral: Sortis

Referral: Sortis

Referral: Daivobet

Referral: Atacand

Referral: Xalatan

Referral: Fortum

Referral: Vascace

Referral: Diovan

Referral: Diovan

Referral: Arimidex

Referral: Topamax

Referral: Meronem

Referral: Diovan Comp

Referral: Zoloft

Referral: Tritace

Referral: Tritazide